Federal contract award
75N92026F00001
[26-000772] NHLBI LABORATORY OF CARDIOVASCULAR REGENERATIVE MEDICINE REQUIRES GEM-X UNIVERSAL 3 GENE EXPRESSION CDNA KIT V4 16 SAMPLES IN ORDER TO CONTINUE PATIENT RELATED EXPERIMENTS ON IN VIVO AND IN VITRO TISSUE SAMPLES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | 75N98022A00032 |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $22.4K |
| Current contract value | $22.4K |
| Potential contract value / ceiling | $22.4K |
| Start date | Dec 8, 2025 |
| Current end date | Mar 8, 2026 |
| Potential end date | Mar 8, 2026 |
| Latest award activity | Dec 11, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 11, 2025 | 0 | $22.4K | [26-000772] NHLBI LABORATORY OF CARDIOVASCULAR REGENERATIVE MEDICINE REQUIRES GEM-X UNIVERSAL 3 GENE EXPRESSION CDNA KIT V4 16 SAMPLES IN ORDER TO CONTINUE PATIENT RELATED EXPERIMENTS ON IN VIVO AND IN VITRO TISSUE SAMPLES |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.